Jefferies Comments on Forest Labs

Loading...
Loading...
Jefferies provided color on Forest Labs
FRX
in a research report published today. Jefferies has previously given Forest Labs a Buy rating and $46 price target. In the report, Jefferies states, "We think most people have missed the fact that in its SEC filing on Friday and its letter to shareholders today to support its proxy battle against Carl Icahn, Forest provided a first-time look at its internal projections for revenue in 2016. The only numbers were a 10% CAGR in revenue and 30% in EPS from F'13- F'17. And FRX stated that F'16 would be "greater than" F'11 (of $4.42B). But individual product projections can be derived." Shares of Forest Labs were trading at $36.71 at the time of posting, down 0.94% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorAnalyst RatingsHealth CareJefferies & CoPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...